Skip to main content
44263 search results for:

Esophageal Cancer 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 01-12-2024 | Esophageal Cancer | OriginalPaper

    Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram

    Malignant esophageal fistula (MEF) is a serious complication of advanced esophageal cancer and is defined as a fistula caused by malignancies [ 1 ]. The two most common types are esophageal mediastinal fistula and esophageal respiratory fistula.

  2. Open Access 01-12-2024 | Esophageal Cancer | OriginalPaper

    Feasibility of utilizing mediastinal drains alone following esophageal cancer surgery: a retrospective study

    Esophageal cancer was a widespread malignant tumor globally, with 604,100 new cases reported worldwide in 2020, ranking eighth in the incidence of malignant tumors globally [ 1 ]. China had a high incidence of esophageal cancer, accounting for over …

  3. 09-03-2024 | Esophageal Cancer | Letter

    Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

  4. Open Access 01-12-2024 | Esophagus Resection | ReviewPaper

    Chylous leakage after esophagectomy for esophageal cancer: a systematic review

    Postesophagectomy chylous leakage is a rare but fatal complication with an incidence rate of 0.4–9% following transthoracic esophagectomy [ 1 ]. Daily chylous leakage after surgery can result in dehydration, electrolyte abnormalities, malnutrition …

  5. 23-04-2024 | Esophageal Cancer | Online First

    Complete Tumor Response of Esophageal Cancer: How Much Imaging Can Do?

  6. Open Access 25-04-2024 | Esophageal Cancer | Online First

    Association between interstitial lung abnormality and mortality in patients with esophageal cancer

    Interstitial lung abnormalities (ILAs) are defined as incidental radiologic patterns in the lungs on computed tomography (CT) including subtle interstitial findings [ 1 ]. ILAs do not necessarily represent a distinct disease, but many previous …

  7. 08-03-2024 | Esophageal Cancer | EditorialNotes

    Adjuvant Nivolumab in Esophageal Cancer with Positive Resection Margins: A Premature Leap?

  8. 30-04-2024 | Esophageal Cancer | Online First

    The efficacy and safety of snare traction-assisted endoscopic submucosal dissection for circumferential superficial esophageal cancer

  9. Open Access 01-12-2024 | Cancer Fatigue | OriginalPaper

    Effects of physical and psychological symptoms on cancer-related fatigue among esophageal cancer patients

    According to CLOBOCAN 2020 [ 1 ], EC is the seventh most commonly diagnosed cancer and the sixth leading cause of cancer death. Eastern Asia has the highest regional incidence rates for both men and women, mainly due to China’s enormous burden [ 2 …

  10. 29-02-2024 | Esophageal Cancer | OriginalPaper

    Body Composition and Clinical Outcomes in Esophageal Cancer Patients Treated with Immune Checkpoint Inhibitors

  11. Open Access 01-12-2024 | Esophageal Cancer | OriginalPaper

    Anlotinib inhibits growth of human esophageal cancer TE-1 cells by negative regulating PI3K/Akt signaling pathway

    Anlotinib is effective in treatment of many kinds of malignant cancer, but its antineoplastic effects on esophageal cancer remains unclear. This study aims to investigate its impact on esophageal cancer and the underlying mechanisms. Anlotiniband …

  12. Open Access 01-12-2024 | Esophageal Cancer | OriginalPaper

    Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid

    Cancer is still the second-leading cause of mortality in the Global [ 1 – 3 ]. In the face of global trends, the burden of cancer on the aging population is increasingly alarming. Notably, there has been a significant rise in the incidence of …

  13. Open Access 01-12-2024 | Esophageal Cancer | OriginalPaper

    Conditional survival and annual hazard of death in older patients with esophageal cancer receiving definitive chemoradiotherapy

    As global populations continue to age, the incidence of cancer is expected to rise significantly. By the year 2030, it is projected that approximately 70% of new cancer cases diagnosed will be in the older [ 1 – 3 ]. Among the various types of …

  14. 02-05-2024 | Online First

    ASO Visual Abstract: Is Robotic Surgery the Future for Resectable Esophageal Cancer?: A Systematic Literature Review of Oncological and Clinical Outcomes

  15. 24-01-2024 | Esophageal Cancer | BriefCommunication

    ASO Author Reflections: Significance of Skeletal Muscle Loss After Neoadjuvant Chemoradiation for Esophageal Cancer

    Many studies and meta-analyses had proven that esophageal cancer patients with sarcopenia had a disadvantage on surgical morbidity and survival benefit. 1 , 2 Sarcopenia, a time-specific body composition, could be diagnosed through assessing …

  16. 15-02-2024 | Abstract

    ASO Visual Abstract: Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients

  17. 29-04-2024 | Online First

    ASO Visual Abstract: Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer During Neoadjuvant Chemoradiation

  18. Open Access 25-04-2024 | Esophageal Cancer | Online First

    How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish study

    Esophageal cancer (EC) is a highly prevalent disease, ranking eighth in cancer incidence worldwide, with over 600,000 new cases diagnosed in 2020, of which 70% are in men [ 1 , 2 ]. Unfortunately, it is often not detected until advanced or …

  19. Open Access 03-04-2024 | Esophageal Cancer | Online First

    Japanese Classification of Esophageal Cancer, 12th Edition: Part I

    This is the first half of English edition of Japanese Classification of Esophageal Cancer, 12th Edition that was published by the Japan Esophageal Society in 2022.

  20. 23-02-2024 | Esophageal Cancer | Letter

    Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.